Bertis Bioscience

Bertis Bioscience Inc., a subsidiary of Bertis, is dedicated to providing a proteomics-based biomarker discovery platform for cancer detection. The company is accelerating the development of proteomics and bioinformatics technologies to offer precision medicine and personalized treatment for pancreatic cancer, breast cancer, and ovarian cancer.